These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16478996)

  • 21. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas.
    Wang JY; Del Valle L; Gordon J; Rubini M; Romano G; Croul S; Peruzzi F; Khalili K; Reiss K
    Oncogene; 2001 Jun; 20(29):3857-68. PubMed ID: 11439349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
    Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
    Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of insulin receptor substrate-1 in transformation by v-src.
    Sun H; Baserga R
    J Cell Physiol; 2008 Jun; 215(3):725-32. PubMed ID: 18064649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
    Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta.
    Toba H; Gomyo E; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Asayama J; Kobara M; Nakata T
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):440-7. PubMed ID: 16700876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
    Li JC; Li R
    Cancer Res; 2007 Sep; 67(18):8856-64. PubMed ID: 17875727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
    Lee CT; Park KH; Adachi Y; Seol JY; Yoo CG; Kim YW; Han SK; Shim YS; Coffee K; Dikov MM; Carbone DP
    Cancer Gene Ther; 2003 Jan; 10(1):57-63. PubMed ID: 12489029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA; Campbell CI; Petrik JJ; Moorehead RA
    Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
    J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis.
    Alexia C; Bras M; Fallot G; Vadrot N; Daniel F; Lasfer M; Tamouza H; Groyer A
    Ann N Y Acad Sci; 2006 Dec; 1090():1-17. PubMed ID: 17384242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905.
    Li S; Zhang H; Hoff H; Sell C
    Exp Cell Res; 1998 Sep; 243(2):326-33. PubMed ID: 9743592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
    Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.
    Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH
    J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.